Literature DB >> 3829287

Use of atracurium in a patient with plasma cholinesterase deficiency.

N Donen.   

Abstract

The use of atracurium during anaesthesia for abdominal hysterectomy in a 37-year-old patient with homozygous plasma cholinesterase [EsEs] deficiency is described. Intubation was achieved utilizing 0.47 mg X kg-1 of atracurium. Subsequent doses of 0.08 mg X kg-1, 0.12 mg X kg-1 and 0.12 mg X kg-1 were given 34, 57 and 78 minutes respectively after the initial dose. At the time of reversal of the residual effects of neuromuscular blockade, 26 minutes after the last dose, spontaneous respiration had resumed. The duration of action of the drug was not different from that described in normal patients. Atracurium would appear to be a safe drug to provide neuromuscular relaxation in patients with plasma cholinesterase deficiency, where surgical procedures of intermediate duration are being undertaken.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3829287     DOI: 10.1007/BF03007688

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  10 in total

1.  Colorimetric determination of serum cholinesterase and its genetic variants by the propionylthiocholine-dithiobis(nitrobenzoic acid)procedure.

Authors:  A A Dietz; H M Rubinstein; T Lubrano
Journal:  Clin Chem       Date:  1973-11       Impact factor: 8.327

2.  Atracurium in a parturient with atypical cholinesterase.

Authors:  A Baraka; C Abu Jaude
Journal:  Br J Anaesth       Date:  1984-08       Impact factor: 9.166

3.  Atracurium v. suxamethonium in a case of organophosphorous poisoning.

Authors:  A Baraka; L Cava; C A Jaoude
Journal:  Br J Anaesth       Date:  1984-06       Impact factor: 9.166

4.  In vitro degradation of atracurium in human plasma.

Authors:  R A Merrett; C W Thompson; F W Webb
Journal:  Br J Anaesth       Date:  1983-01       Impact factor: 9.166

Review 5.  Plasma cholinesterase variants and the anaesthetist.

Authors:  M Whittaker
Journal:  Anaesthesia       Date:  1980-02       Impact factor: 6.955

6.  Metabolism and kinetics of atracurium: an overview.

Authors:  E A Neill; D J Chapple; C W Thompson
Journal:  Br J Anaesth       Date:  1983       Impact factor: 9.166

7.  Atracurium: conception and inception.

Authors:  J B Stenlake; R D Waigh; J Urwin; G H Dewar; G G Coker
Journal:  Br J Anaesth       Date:  1983       Impact factor: 9.166

8.  Muscular relaxation with atracurium, vecuronium and duador under balanced anaesthesia.

Authors:  F F Foldes; H Nagashima; M Boros; E Tassonyi; S Fitzal; S Agoston
Journal:  Br J Anaesth       Date:  1983       Impact factor: 9.166

9.  Inactivation of atracurium in human and rat plasma.

Authors:  V Nigrovic; J B Pandya; M Auen; A Wajskol
Journal:  Anesth Analg       Date:  1985-11       Impact factor: 5.108

10.  Clinical pharmacology of atracurium besylate (BW 33A): a new non-depolarizing muscle relaxant.

Authors:  S J Basta; H H Ali; J J Savarese; N Sunder; M Gionfriddo; G Cloutier; C Lineberry; A E Cato
Journal:  Anesth Analg       Date:  1982-09       Impact factor: 5.108

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.